View Author
patient tumor survival study prognostic anaplastic cancer diagnosis necrosis trial radiotherapy treatment analysis glioblastoma oligodendroglioma glioma group table factor oligodendroglial outcome feature review temozolomide anaplastic oligodendroglial tumors fication eortc status value research chromosome oligoastrocytoma ina expression genomic signi expression 1 ploss 19qloss oncol number anaplastic oligodendroglioma chemotherapy mutation consensus anaplastic oligoastrocytoma pathology 1.00 month 1 p /19q neuropathol gbm-o grade ampli department signi ficantly prognostic value university oligodendroglial tumors progression-free survival methylation abnormality phase bene fit adjuvant multivariate analysis reviewer promoter egfr ampli fication erasmus university rotterdam prognostic significance presence analyses identi european significance pathology review oligodendroglioma-like component j clin oncol pathologist tissue neurol
6 Most Recent Publications
|
Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial
(Article)
Hegi, M.E. Janzer, R.C. Hamou, M.F. Bady, P. Weller, M. Bent, M.J. van den Mason, W.P. Mirimanoff, R.O. Stupp, R. Mokhtari, K. Wesseling, P. Lambiv, W.L. Gorlia, T. Kouwenhoven, M.C.M. Hartmann, C. Deimling, A. von Martinet, D. Besuchet Schmutz, N. Diserens, A.C. |
2012-01-16
|
|
Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy
(Article)
Mokhtari, K. Ducray, F. Kros, J.M. Gorlia, T. Idbaih, A. Taphoorn, M.J.B. Wesseling, P. Hoang-Xuan, K. Bent, M.J. van den Sanson, M. |
2011-07-01
|
|
Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951
(Article)
Idbaih, A. Dalmasso, C. Delattre, O. Mokhtari, K. Sanson, M. Bent, M.J. van den Hoang-Xuan, K. Kouwenhoven, M.C.M. Jeuken, J. Carpentier, C. Gorlia, T. Kros, J.M. French, P.J. Teepen, J.L.J.M. Broët, P. |
2011-06-01
|
|
Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951
(Article)
Kouwenhoven, M.C.M. Gorlia, T. Vandenbos, F. Grisold, W. Sipos, L. Mirimanoff, R.O. Vecht, C.J. Allgeier, A. Lacombe, D. Bent, M.J. van den Kros, J.M. Ibdaih, A. Brandes, A. Bromberg, J.E.C. Mokhtari, K. Duinen, S.G. van Teepen, J.L.J.M. Wesseling, P. |
2009-12-01
|
|
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
(Article)
Stupp, R. Hegi, M.E. Hau, P. Brandes, A. Gijtenbeek, J. Marosi, C. Vecht, C.J. Mokhtari, K. Wesseling, P. Villa, S. Eisenhauer, E. Gorlia, T. Mason, W.P. Weller, M. Lacombe, D. Cairncross, J.G. Mirimanoff, R.O. Bent, M.J. van den Taphoorn, M.J. Janzer, R.C. Ludwin, S.K. Allgeier, A. Fisher, B. Belanger, K. |
2009-05-01
|
|
Panel review of anaplastic oligodendroglioma from European organization for research and treatment of cancer trial 26951: Assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome
(Article)
Kros, J.M. Gorlia, T. Paetau, A. Reifenberger, G. Bent, M.J. van den Kouwenhoven, M.C.M. Zheng, P.P. Collins, V.P. Figarella-Branger, D. Giangaspero, F. Giannini, C. Mokhtari, K. Mørk, S.J. |
2007-06-01
|
